Long-term quality-of-life outcomes following prostate radiotherapy with or without high-dose-rate brachytherapy boost: post-hoc analysis of TROG 03.04 RADAR

- Ong, Wee Loon, Nikitas, John, Nickols, Nicholas G., Chang, Albert, Zaorsky, Nicholas G., Spratt, Daniel E., Romero, Tahmineh, Kishan, Amar U., Joseph, David, Steigler, Allison, Millar, Jeremy, Valle, Luca, Steinberg, Michael L., Martin, Ting, Reiter, Robert E., Rettig, Matthew B.

Androgen deprivation therapy use and duration with definitive radiotherapy for localised prostate cancer: an individual patient data meta-analysis

- Kishan, Amar U., Sun, Yilun, Armstrong, John G., Nabid, Abdenour, Carrier, Nahtalie, Souhami, Luis, Dunne, Mary T., Efstathiou, Jason A., Sandler, Howard M., Guerrero, Araceli, Joseph, David, Maingon, Philippe, Hartman, Holly, de Reijke, Theo M., Maldonado, X, Ma, TM, Romero, T, Wang, X, Rettig, MB, Reiter, RE, Zaorsky, NG, Steinberg, ML, Nickols, NG, Pisansky, Thomas M., Jia, AY, Garcia, JA, Spratt, DE, Bolla, Michel, Neven, Anouk, Steigler, Allison, Denham, James W., Feng, Felix Y., Zapatero, Almudena

High-dose Radiotherapy or Androgen Deprivation Therapy (HEAT) as Treatment Intensification for Localized Prostate Cancer: An Individual Patient–data Network Meta-analysis from the MARCAP Consortium

- Kishan, Amar U., Wang, Xiaoyan, De Reijke, Theo, Neven, Anouk, Steigler, Allison, Denham, James W., Joseph, David, Nabid, Abdenour, Carrier, Nathalie, Souhami, Luis, Sydes, Matt R., Dearnaley, David P., Sun, Yilun, Syndikus, Isabel, Tree, AC, Incrocci, L, Heemsbergen, WD, Pos, FJ, Zapatero, A, Efstathiou, JA, Guerrero, A, Alvarez, A, San-Segundo, CG, Romero, Tahmineh, Maldonado, X, Xiang, M, Rettig, MB, Reiter, RE, Zaorsky, NG, Ong, WL, Dess, RT, Steinberg, ML, Nickols, NG, Roy, S, Michalski, Jeff M., Garcia, JA, Spratt, DE, MARCAP Consortium,, Ma, Ting Martin, Feng, Felix Y., Sandler, Howard M., Bolla, Michel, Maingon, Philippe

Local Failure Events in Prostate Cancer Treated with Radiotherapy: A Pooled Analysis of 18 Randomized Trials from the Meta-analysis of Randomized Trials in Cancer of the Prostate Consortium (LEVIATHAN)

- Ma, Ting Martin, Chu, Fang-I, Bolla, Michel, de Reijke, Theo M., Maingon, Philippe, Neven, Anouk, Denham, James, Steigler, Allison, Joseph, David J., Nabid, Abdenour, Souhami, Luis, Carrier, Nathalie, Sandler, Howard, Incrocci, Luca, Heemsbergen, Wilma, Pos, Floris J., Sydes, Matthew R., Dearnaley, David P., Tree, Alison C., Syndikus, Isabel, Hall, Emma, Cruickshank, Clare, Malone, Shawn, Feng, Felix Y., Roy, Soumyajit, Sun, Yilun, Zaorsky, Nicholas G., Nickols, Nicholas G., Reiter, Robert E., Rettig, Matthew B., Steinberg, Michael L., Reddy, Vishruth K., Xiang, Michael, Romero, Tahmineh, Efstathiou, Jason A., Spratt, Daniel E., Kishan, Amar U., Meta-analysis of Randomized trials in Cancer of the Prostate MARCAP Consortium investigators,, Jones, Christopher U., Roach, Mack, Rosenthal, Seth A., Pisansky, Thomas, Michalski, Jeff M.

External validation of a predictive model of urethral strictures for prostate patients treated with HDR Brachytherapy boost

- Panettieri, Vanessa, Rancati, Tiiziana, Onjukka, Eva, Ebert, Martin A., Joseph, David J., Denham, James W., Steigler, Allison, Millar, Jeremy L.

Increased dose to organs in urinary tract associates with measures of genitourinary toxicity in pooled voxel-based analysis of 3 randomized phase III trials

- Marcello, Marco, Denham, James W., Kennedy, Angel, Haworth, Annette, Steigler, Allison, Greer, Peter B., Holloway, Lois C., Dowling, Jason A., Jameson, Michael G., Roach, Dale, Joseph, David J., Gulliford, Sarah L., Dearnaley, David P., Sydes, Matthew R., Hall, Emma, Ebert, Martin A.

Perineural invasion by prostate adenocarcinoma in needle biopsies predicts bone metastasis: Ten year data from the TROG 03.04 RADAR Trial

- Delahunt, Brett, Murray, Judith D., Steigler, Allison, Atkinson, Chris, Christie, David, Duchesne, Gillian, Egevad, Lars, Joseph, David, Matthews, John, Oldmeadow, Christopher, Samaratunga, Hemamali, Spry, Nigel A., Srigley, John R., Hondermarck, Hubert, Denham, James W.

Radiation Dose Escalation or Longer Androgen Suppression to Prevent Distant Progression in Men With Locally Advanced Prostate Cancer: 10-Year Data From the TROG 03.04 RADAR Trial

- Joseph, David, Denham, James W., Turner, Sandra, Kenny, Lizbeth, Christie, David, Tai, Keen-Hun, Gogna, NirdoshK, Kearvell, Rachel, Murray, Judy, Ebert, Martin A., Haworth, Annette, Delahunt, Brett, Steigler, Allison, Oldmeadow, Christopher, Attia, John, Lamb, David S., Spry, Nigel A., Stanley, John, Shannon, Tom, Duchesne, Gillian, Atkinson, Chris, Matthews, John H. L.

Rectal and Urethro-Vesical Subregions for Toxicity Prediction After Prostate Cancer Radiation Therapy: Validation of Voxel-Based Models in an Independent Population

- Mylona, Eugenia, Ebert, Martin, Kennedy, Angel, Joseph, David, Denham, James, Steigler, Allison, Supiot, Stephane, Acosta, Oscar, de Crevoisier, Renaud

Reduced dose posterior to prostate correlates with increased PSA progression in voxel-based analysis of 3 randomized phase 3 trials

- Marcello, Marco, Denham, James W., Joseph, David J., Gulliford, Sarah L., Dearnaley, David P., Sydes, Matthew R., Hall, Emma, Ebert, Martin A., Kennedy, Angel, Haworth, Annette, Steigler, Allison, Greer, Peter B., Holloway, Lois C., Dowling, Jason A., Jameson, Michael G., Roach, Dale

Relationships between rectal and perirectal doses and rectal bleeding or tenesmus in pooled voxel-based analysis of 3 randomised phase III trials

- Marcello, Marco, Denham, James W., Kennedy, Angel, Haworth, Annette, Steigler, Allison, Greer, Peter B., Holloway, Lois C., Dowling, Jason A., Jameson, Michael G., Roach, Dale, Joseph, David J., Gulliford, Sarah L., Dearnaley, David P., Sydes, Mathew R., Hall, Emma, Ebert, Martin A.

Tumour innervation and neurosignalling in prostate cancer

- March, Brayden, Faulkner, Sam, Jobling, Phillip, Steigler, Allison, Blatt, Alison, Denham, Jim, Hondermarck, Hubert

Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): 10-year results from a randomised, phase 3, factorial trial

- Denham, James W., Joseph, David, Lamb, David S., Spry, Nigel A., Duchesne, Gillian, Matthews, John, Atkinson, Chris, Tai, Keen-Hun, Christie, David, Kenny, Lizbeth, Turner, Sandra, Gogna, Nirdosh Kumar, Diamond, Terry, Delahunt, Brett, Oldmeadow, Chris, Attia, John, Steigler, Allison

Association between measures of treatment quality and disease progression in prostate cancer radiotherapy: An exploratory analysis from the TROG 03.04 RADAR trial

- Marcello, Marco, Ebert, Martin A., Haworth, Annette, Steigler, Allison, Kennedy, Angel, Bulsara, Max, Kearvell, Rachel, Joseph, David J., Denham, James W.

Association between treatment planning and delivery factors and disease progression in prostate cancer radiotherapy: Results from the TROG 03.04 RADAR trial

- Marcello, Marco, Ebert, Martin, Haworth, Annette, Steigler, Allison, Kennedy, Angel, Joseph, David, Denham, James

Measuring personal and functional changes in prostate cancer survivors: development and validation of the FADE: data from the TROG 03.04 RADAR trial

- Bitsika, Vicki, Sharpley, Christopher F., Christie, David R. H., Bradford, Rosemary, Steigler, Allison, Denham, James W.

Psychological resilience aspects that mediate the depressive effects of urinary incontinence in prostate cancer survivors 10 years after treatment with radiation and hormone ablation

- Sharpley, Christopher F., Bitsika, Vicki, Christie, David R. H., Bradford, Rosemary, Steigler, Allison, Denham, James W.

Oligometastatic bone disease in prostate cancer patients treated on the TROG 03.04 RADAR trial

- Sridharan, Swetha, Steigler, Allison, Attia, John, Holliday, Elizabeth G., Denham, James W., Spry, Nigel A., Joseph, David, Lamb, David S., Matthews, John H., Atkinson, Chris, Tai, Keen-Hun, Duchesne, Gillian, Christie, David

Radiation dose escalation or longer androgen suppression for locally advanced prostate cancer? Data from the TROG 03.04 RADAR trial

- Denham, James W., Steigler, Allison, Tai, Keen-Hun, Gogna, Nirdosh Kumar, Gill, Suki, Tan, Hendrick, Kearvell, Rachel, Murray, Judy, Ebert, Martin, Haworth, Annette, Kennedy, Angel, Delahunt, Brett, Joseph, David, Oldmeadow, Christopher, Holliday, Elizabeth G., Attia, John, Lamb, David S., Spry, Nigel A., Duchesne, Gillian, Atkinson, Chris, Matthews, John, Turner, Sandra, Kenny, Lizbeth

Paradoxical metastatic progression following 3 months of neo-adjuvant androgen suppression in the TROG 96.01 trial for men with locally advanced prostate cancer

- Denham, James W., Steigler, Allison, Wynne, Chris, Lamb, David S., Tai, Keen-Hun, Joseph, David, Matthews, John, Atkinson, Chris, Spry, Nigel A., Turner, Sandra, North, John, Christie, David